• 한국해양학회지:바다
• /
• 제12권4호
• /
• pp.337-348
• /
• 2007

아산만에서 장마기 전 후 수온, 염분, 영양염, chlorophyll ${\alpha}$ 농도와 중형동물플랑크톤 등에 대해 분포의 특성과 이들 간의 관계를 파악해 보았다. 장마기에 담수 유입에 의한 환경 변화는 동물플랑크톤과 식물플랑크톤(chlorophyll ${\alpha}$) 분포에 직접적인 영향을 주었다. 장마기에 유입된 담수로 인해 영양염 농도는 높아졌고 동물플랑크톤 개체수는 크게 감소하였다. 반면, 식물플랑크톤(chlorophyll ${\alpha}$)은 장마기 종료 시점에 생체량이 증가하였다. 이는 방조제로부터 유출수 증가에 따른 동물플랑크톤 감소와 영양염 유입의 증가가 나타난 후 식물플랑크톤의 생체량이 증가하는 생물학적 과정이 연결되어 나타난 것으로 판단된다. 동물플랑크톤의 분포는 수온 변화에 따라 종별로 다른 양상을 보여 봄철 우점종과 여름철 우점종으로 구분 지을 수 있게 하였다. 이는 수온이 역시 중요한 분포요인이 됨을 보여준다. 그러나 장마로 인한 염분 변화는 전체 동물플랑크톤의 분포에 큰 영향을 주었으며 특히, Noctiluca scintillans, Acartia pacifica, Sagitta crassa에게는 수온보다 장마로 인한 염분 변화가 더 크게 작용한 것으로 판단되었다.

• Journal of Preventive Medicine and Public Health
• /
• 제57권2호
• /
• pp.185-196
• /
• 2024

Objectives: Excess mortality associated with long-term exposure to fine particulate matter (PM_2.5) has been documented. However, research on the disease burden following short-term exposure is scarce. We investigated the cause-specific mortality burden of short-term exposure to PM_2.5 by considering the potential non-linear concentration-response relationship in Korea. Methods: Daily cause-specific mortality rates and PM_2.5 exposure levels from 2010 to 2019 were collected for 8 Korean cities and 9 provinces. A generalized additive mixed model was employed to estimate the non-linear relationship between PM_2.5 exposure and cause-specific mortality levels. We assumed no detrimental health effects of PM_2.5 concentrations below 15 ㎍/m³. Overall deaths attributable to short-term PM_2.5 exposure were estimated by summing the daily numbers of excess deaths associated with ambient PM_2.5 exposure. Results: Of the 2 749 704 recorded deaths, 2 453 686 (89.2%) were non-accidental, 591 267 (21.5%) were cardiovascular, and 141 066 (5.1%) were respiratory in nature. A non-linear relationship was observed between all-cause mortality and exposure to PM_2.5 at lag0, whereas linear associations were evident for cause-specific mortalities. Overall, 10 814 all-cause, 7855 non-accidental, 1642 cardiovascular, and 708 respiratory deaths were attributed to short-term exposure to PM_2.5. The estimated number of all-cause excess deaths due to short-term PM_2.5 exposure in 2019 was 1039 (95% confidence interval, 604 to 1472). Conclusions: Our findings indicate an association between short-term PM_2.5 exposure and various mortality rates (all-cause, non-accidental, cardiovascular, and respiratory) in Korea over the period from 2010 to 2019. Consequently, action plans should be developed to reduce deaths attributable to short-term exposure to PM_2.5.

• Journal of Trauma and Injury
• /
• 제37권1호
• /
• pp.28-36
• /
• 2024

Purpose: Recent advancements in interventional radiology have made angioembolization an invaluable modality in trauma care. Angioembolization is typically performed by interventional radiologists. In this study, we aimed to investigate the safety and efficacy of emergency angioembolization performed by trauma surgeons. Methods: We identified trauma patients who underwent emergency angiography due to significant trauma-related hemorrhage between January 2020 and June 2023 at Jeju Regional Trauma Center. Until May 2022, two dedicated interventional radiologists performed emergency angiography at our center. However, since June 2022, a trauma surgeon with a background and experience in vascular surgery has performed emergency angiography for trauma-related bleeding. The indications for trauma surgeon-performed angiography included significant hemorrhage from liver injury, pelvic injury, splenic injury, or kidney injury. We assessed the angiography results according to the operator of the initial angiographic procedure. The term "failure of the first angioembolization" was defined as rebleeding from any cause, encompassing patients who underwent either re-embolization due to rebleeding or surgery due to rebleeding. Results: No significant differences were found between the interventional radiologists and the trauma surgeon in terms of re-embolization due to rebleeding, surgery due to rebleeding, or the overall failure rate of the first angioembolization. Mortality and morbidity rates were also similar between the two groups. In a multivariable logistic regression analysis evaluating failure after the first angioembolization, pelvic embolization emerged as the sole significant risk factor (adjusted odds ratio, 3.29; 95% confidence interval, 1.05-10.33; P=0.041). Trauma surgeon-performed angioembolization was not deemed a significant risk factor in the multivariable logistic regression model. Conclusions: Trauma surgeons, when equipped with the necessary endovascular skills and experience, can safely perform angioembolization. To further improve quality control, an enhanced training curriculum for trauma surgeons is warranted.

• Korean Circulation Journal
• /
• 제54권7호
• /
• pp.398-406
• /
• 2024

Background and Objectives: Optimal anticoagulation in very elderly patients is challenging due to the high risk of anticoagulant-induced bleeding. The aim of this study was to assess outcomes of on-label reduced-dose edoxaban (30 mg) in very elderly patients who had additional risk factors for bleeding. Methods: This was a multi-center, prospective, non-interventional observational study to evaluate the efficacy and safety of on-label reduced-dose edoxaban in atrial fibrillation (AF) patients 80 years of age or older and who had more than 1 risk factor for bleeding. Results: A total of 2448 patients (mean age 75.0±8.3 years, 801 [32.7%] males) was included in the present study, and 586 (23.9%) were 80 years of age or older with additional risk factors for bleeding. Major bleeding events occurred frequently among very elderly AF patients who had additional bleeding risk factors compared to other patients (unadjusted hazard ratio [HR], 2.16; 95% confidence interval [CI], 1.16-4.02); however, there were no significant differences in stroke incidence (HR, 1.86; 95% CI, 0.98-3.55). There were no significant differences for either factor after adjusting for age and sex (adjusted HR, 1.65; 95% CI, 0.75-3.62 for major bleeding; adjusted HR, 1.13; 95% CI, 0.51-2.50 for stroke). Conclusions: In very elderly AF patients with comorbidities associated with greater risk of bleeding, the incidence of major bleeding events was significantly increased. In addition, risk of stroke showed tendency to increase in same population. Effective anticoagulation therapy might be important in these high-risk population, and close observation of bleeding events might also be required.

• Korean Circulation Journal
• /
• 제52권4호
• /
• pp.304-319
• /
• 2022

Background and Objectives: De-escalation of dual-antiplatelet therapy through dose reduction of prasugrel improved net adverse clinical events (NACEs) after acute coronary syndrome (ACS), mainly through the reduction of bleeding without an increase in ischemic outcomes. Whether the benefits of de-escalation are sustained in highly thrombotic conditions such as ST-elevation myocardial infarction (STEMI) is unknown. We aimed to assess the efficacy and safety of de-escalation therapy in patients with STEMI or non-ST-segment elevation ACS (NSTE-ACS). Methods: This is a pre-specified subgroup analysis of the HOST-REDUCE-POLYTECH-ACS trial. ACS patients were randomized to prasugrel de-escalation (5 mg daily) or conventional dose (10 mg daily) at 1-month post-percutaneous coronary intervention. The primary endpoint was a NACE, defined as a composite of all-cause death, non-fatal myocardial infarction, stent thrombosis, clinically driven revascularization, stroke, and bleeding events of grade ≥2 Bleeding Academic Research Consortium (BARC) criteria at 1 year. Results: Among 2,338 patients included in the randomization, 326 patients were diagnosed with STEMI. In patients with NSTE-ACS, the risk of the primary endpoint was significantly reduced with de-escalation (hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.48-0.89; p=0.006 for de-escalation vs. conventional), mainly driven by a reduced bleeding. However, in those with STEMI, there was no difference in the occurrence of the primary outcome (HR, 1.04; 95% CI, 0.48-2.26; p=0.915; p for interaction=0.271). Conclusions: Prasugrel dose de-escalation reduced the rate of NACE and bleeding, without increasing the rate of ischemic events in NSTE-ACS patients but not in STEMI patients.

• Annals of Occupational and Environmental Medicine
• /
• 제34권
• /
• pp.40.1-40.9
• /
• 2022

Background: According to the occupational accident status analysis in 2020, of 1,180 occupational deaths, 463 were caused by cardiovascular disease (CVD). Workers should be assessed for CVD risk at regular intervals to prevent work-related CVD in accordance with the rules on occupational safety and health standards. However, no previous study has addressed risk and mortality. Therefore, this longitudinal study was conducted to evaluate the relationship between 10-year cardiovascular risk of the general health checkup and mortality. Methods: The study included 545,859 participants who visited Kangbuk Samsung Total Healthcare Centers from January 1, 2002, to December 31, 2017. We performed 10-year cardiovascular risk assessment for the participants and the risk was divided into 4 groups (low, moderate, high, and very high). The study used death data from the Korea National Statistical Office for survival status as an outcome variable by December 31, 2019, and the cause of death based on the International Classification of Diseases, 10^th Revision (ICD-10) was identified. Statistical analysis was performed using Cox proportional hazards regression analysis, and the sum of the periods from the first visit to the date of death or December 31, 2019, was used as a time scale. We also performed a stratified analysis for age at baseline and sex. Results: During 5,253,627.9 person-years, 4,738 overall deaths and 654 cardiovascular deaths occurred. When the low-risk group was set as a reference, in the multivariable-adjusted model, the hazard ratios (HRs) (95% confidence interval [CI]) for overall mortality were 3.36 (2.87-3.95) in the moderate-risk group, 11.08 (9.27-13.25) in the high-risk group, and 21.20 (17.42-25.79) in the very-high-risk group, all of which were statistically significant. In cardiovascular deaths, the difference according to the risk classification was more pronounced. The HRs (95% CI) were 8.57 (4.95-14.83), 38.95 (21.77-69.69), and 78.81 (42.62-145.71) in each group. As a result of a subgroup analysis by age and sex, the HRs of all-cause mortality and cardiovascular mortality tended to be higher in the high-risk group. Conclusions: This large-scale longitudinal study confirmed that the risk of death increases with the 10-year cardiovascular risk of general health checkup.

• 생물환경조절학회지
• /
• 제22권4호
• /
• pp.371-377
• /
• 2013

고추 수급 안정대책의 일환으로 정부에서는 2012년부터 고추 비가림시설 지원 사업을 실시하고 있지만 현재 농가에 보급되고 있는 단동 비닐하우스는 측고가 낮아 고추 비가림재배에 부적합한 면이 있다. 본 연구에서는 고추 재배에 적합한 규격을 가지면서 구조적으로도 안전한 고추 비가림재배용 단동 비닐하우스를 개발하고자 하였다. 전국 56개 고추 비가림재배 농가를 대상으로 비닐하우스 구조실태 및 구조개선 희망사항을 조사하여 비닐하우스 폭과 높이를 설정하였다. 현재 운용중인 비닐하우스의 폭은 7m 미만이 53%를, 측고는 1.5m 이하가 64%로 가장 높은 비율을 차지하였다. 희망하는 하우스의 폭은 7.0m, 측고는 2.0m를 선호하는 농가가 가장 많아서 이 규격으로 결정하였다. 서까래 파이프 규격을 다양하게 변화시켜가면서 구조안전성을 분석한 후 골조율과 설치비 등을 고려하여 5종의 모델을 제시하였다. 12-고추-1형은 ${\emptyset}42.2{\times}2.1t$의 서까래 파이프를 90cm 간격, 12-고추-2형부터 5형은 ${\emptyset}31.8{\times}1.5t$의 서까래 파이프를 각각 60cm, 70cm, 80cm 및 90cm 간격으로 설치하는 모델이다. 농림수산식품부 고시 10-단동-3형과 비교하여 12-고추-2형의 경제성을 분석한 결과, $672m^2$ 면적의 하우스 1동 기준으로 약 120만원의 소득 증가가 있는 것으로 나타났다.

• 한국식품위생안전성학회지
• /
• 제24권3호
• /
• pp.194-199
• /
• 2009

매실주 숙성중 매실부위, 알콜농도 및 t-resveratrol 이 에틸카바메이트 생성에 미치는 영향을 알아 보고자 매실주를 조제하여 6개월간 저장하면서 에틸카바메이트 생성량을 조사한 결과 30% 알콜 매실주의 경우 최대 $0.188{\mu}g$/g이 생성 되었으며, 30% 알콜 매실주에 t-resveratrol를 $10{\mu}g$/g 및 $300{\mu}g$/g 농도로 첨가시에는 각각 0.216 및 $0.169{\mu}g$/g 이 생성 되었다. 16% 알콜 매실주 에서는 최대 $0.071{\mu}g$/g 이 생성 되었고, 16% 알콜 매실주에 t-resveratrol 를 10 및 $300{\mu}g$/g농도로 첨가시는 모두 $0.078{\mu}g$/g의 에틸카바메이트가 생성되었다. 매실 과육만으로 매실주를 조제시 에틸카바메이트는 생성되지 않았으며 매실씨 만으로 조제시는 최대 $0.588{\mu}g$/g, 씨에 t-resveratrol 를 $300{\mu}g$/g 첨가시 $0.676{\mu}g$/g 의 에틸카바메이트가 생성되어 t-resveratrol 첨가가 에틸카바메이트 생성을 감소 시키지 못하는 것으로 조사되었다.

• 한국환경농학회지
• /
• 제30권2호
• /
• pp.160-165
• /
• 2011

시설재배지내의 밀폐공간에서 토양처리농약의 살포 후 농작업으로 작업자의 농약중독 우려가 상존하므로 농약중독예방 방지를 위해 살포농약의 휘산양상과 농작업자 노출량 산정 연구를 수행하였다. 흡착제를 이용한 공기 중 ethoprophos, cardusafos, probenazole의 회수율은 각각 charcoal 흡착제 80.9~121.1%, XAD-4 흡착제가 90.6~99.0% 수준으로 양호하였다. lysimeter에 토양을 혼화처리 한 후 온도별 농약의 휘산은 온도가 높을수록 휘산이 잘되었으며, 특히 수분이 존재 하는 $35^{\circ}C$조건에서는 ethoprophos의 경우 3~5배 휘산량이 증가하였다. 면적 245 $m^2$ 시설하우스 재배포장에서 ethoprophos 입제를 150 g (a.i.) 토양과 혼화처리하고 지면으로부터 50 cm 상층에서 처리 46시간까지 토양처리제인 ethoprophos의 휘산량은 17.8~186.4 ${\mu}g/m^3$이었다. 동일조건에서 cadusafos 180 g a.i./245 $m^2$ 약량을 처리했을 때 처리 39시간째에 최고 농도를 보였으며 46시간까지 공기중농도는 10.0~37.3 ${\mu}g/m^3$이었다. Probenazole은 144 g a.i./245 $m^2$ 약량을 처리했을 때 처리 37시간째에 최고 농도를 보였으며 46시간까지의 공기중 농도는 0.23~1.45 ${\mu}g/m^3$ 수준이었다. 약제처리 후 하우스내 공기중 농약성분의 최대잔류량은 13~39시간 사이에 최대잔류가 되었고 토양처리농약인 ethoprophos 입제와 cadusafos 입제는 휘산성이 높음으로 농작업자 재출입 기간은 살포 후 48시간 이후로 설정해야 할것이다.

• 한국식품위생안전성학회:학술대회논문집
• /
• 한국식품위생안전성학회 2004년도 추계심포지움 및 학술발표회 : 건강기능식품의 안전성 평가와 개발
• /
• pp.50-58
• /
• 2004

성인을 대상으로 펩타이드의 강압효과를 검토하기 위해, 경증고혈압증군(輕症高血壓症群) (평균연령 50.2${\pm}$5.6세, 남9명, 여1명) 및 정상고혈압군 (평균연령 47.7${\pm}$2.8세, 남9명) 에 있어서, 플라시보를 이용한 2중맹검법(2重盲檢法)에 따른 비교대조시험을 실시했다. 경증고혈압증군에서는 Valy-Tyrosine(VY) 환산으로 125${\mu}$g/day의 '펩타이드 음료'에 의해 혈압 저하의 경향이 확인되었고 VY 환산250${\mu}$g/day의 펩타이드 음용량으로 플라시보군에 비해서 유의한 강압이 확인되었다. (음용개시 4주후에서 수축기혈압 17.8${\pm}$2.5mmHg: p <0.01, 확장기혈압 11.0${\pm}$2.0mmHg: p (0.05). 정상고치혈압군(正常高値血壓群)에서는 유의한 혈압강하를 확인하지 못했다. 양 군(群)에서 공히 심박수의 변화는 없었다. 경증고혈압군 (평균연령 50.6${\pm}$4.6세, 남10명) 에 있어서 VY 125${\mu}$g/day의 음용량에서는 전후기 각 4주간의 비교대조교차실험을 했다. 펩타이드 전기 음용군(0-4주)에서는, 음용개시 1주후에 수축기 · 확장기 혈압 모두 유의한 혈압저하작용이 확인되었다. (수축기혈압의 변화율-6.9%, 확장기혈압의 변화율-5.8%, p <0.05) 펩타이드 후기 음용군(10-14주)에서는, 수축기혈압이 음용개시 3주후(변화율-6.7%, p <0.05)에, 확장기혈압이 음용개시 2주후(변화율 6.0%, p <0.05)에 각각 유의한 강압이 확인되었다. 양 군 모두 음용 중지 후에 혈압의 완만한 복귀가 관찰되었다. 전 대상자에 있어서 자각증상, 타각소견(他覺所見)과 함께 이상(異常)은 확인되지 않았으며 부작용도 없었다. 이상의 결과로부터, ‘펩타이드 음료’는 경증고혈압 혹은 경계역고혈압자(境界域高血壓者)의 혈압을, 자각증상 및 혈액${\cdot}$뇨검사에도 전혀 영향을 미치지 않고 저하시킨다고 결론지었다.